BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17959910)

  • 1. Agonist-occupied A3 adenosine receptors exist within heterogeneous complexes in membrane microdomains of individual living cells.
    Cordeaux Y; Briddon SJ; Alexander SP; Kellam B; Hill SJ
    FASEB J; 2008 Mar; 22(3):850-60. PubMed ID: 17959910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct visualisation of internalization of the adenosine A3 receptor and localization with arrestin3 using a fluorescent agonist.
    Stoddart LA; Vernall AJ; Briddon SJ; Kellam B; Hill SJ
    Neuropharmacology; 2015 Nov; 98():68-77. PubMed ID: 25937210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient G protein coupling is not required for agonist-mediated internalization and membrane reorganization of the adenosine A
    Stoddart LA; Kilpatrick LE; Corriden R; Kellam B; Briddon SJ; Hill SJ
    FASEB J; 2021 Apr; 35(4):e21211. PubMed ID: 33710641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of antagonist-occupied adenosine-A3 receptors within membrane microdomains of individual cells provides evidence of receptor dimerization and allosterism.
    Corriden R; Kilpatrick LE; Kellam B; Briddon SJ; Hill SJ
    FASEB J; 2014 Oct; 28(10):4211-22. PubMed ID: 24970394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells.
    Middleton RJ; Briddon SJ; Cordeaux Y; Yates AS; Dale CL; George MW; Baker JG; Hill SJ; Kellam B
    J Med Chem; 2007 Feb; 50(4):782-93. PubMed ID: 17249651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000.
    Gao ZG; Ye K; Göblyös A; Ijzerman AP; Jacobson KA
    BMC Pharmacol; 2008 Dec; 8():20. PubMed ID: 19077268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of fluorescence correlation spectroscopy to the measurement of agonist binding to a G-protein coupled receptor at the single cell level.
    Briddon SJ; Middleton RJ; Yates AS; George MW; Kellam B; Hill SJ
    Faraday Discuss; 2004; 126():197-207; discussion 245-54. PubMed ID: 14992407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of adenosine derivatives as A
    Bednarska-Szczepaniak K; Mieczkowski A; Kierozalska A; Pavlović Saftić D; Głąbała K; Przygodzki T; Stańczyk L; Karolczak K; Watała C; Rao H; Gao ZG; Jacobson KA; Leśnikowski ZJ
    Eur J Med Chem; 2021 Nov; 223():113607. PubMed ID: 34171656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cells.
    Briddon SJ; Middleton RJ; Cordeaux Y; Flavin FM; Weinstein JA; George MW; Kellam B; Hill SJ
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4673-8. PubMed ID: 15070776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioligand binding and functional responses of ligands for human recombinant adenosine A(3) receptors.
    Yates L; Clark JH; Martin TJ; James S; Broadley KJ; Kidd EJ
    Auton Autacoid Pharmacol; 2006 Apr; 26(2):191-200. PubMed ID: 16553647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly potent and selective fluorescent antagonists of the human adenosine A₃ receptor based on the 1,2,4-triazolo[4,3-a]quinoxalin-1-one scaffold.
    Vernall AJ; Stoddart LA; Briddon SJ; Hill SJ; Kellam B
    J Med Chem; 2012 Feb; 55(4):1771-82. PubMed ID: 22277057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: insight into the receptor activation switch.
    Dal Ben D; Buccioni M; Lambertucci C; Kachler S; Falgner N; Marucci G; Thomas A; Cristalli G; Volpini R; Klotz KN
    Biochem Pharmacol; 2014 Jan; 87(2):321-31. PubMed ID: 24161786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists.
    Pal S; Choi WJ; Choe SA; Heller CL; Gao ZG; Chinn M; Jacobson KA; Hou X; Lee SK; Kim HO; Jeong LS
    Bioorg Med Chem; 2009 May; 17(10):3733-8. PubMed ID: 19375920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization by flow cytometry of fluorescent, selective agonist probes of the A(3) adenosine receptor.
    Kozma E; Gizewski ET; Tosh DK; Squarcialupi L; Auchampach JA; Jacobson KA
    Biochem Pharmacol; 2013 Apr; 85(8):1171-81. PubMed ID: 23376019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions.
    Tosh DK; Deflorian F; Phan K; Gao ZG; Wan TC; Gizewski E; Auchampach JA; Jacobson KA
    J Med Chem; 2012 May; 55(10):4847-60. PubMed ID: 22559880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric interactions across native adenosine-A3 receptor homodimers: quantification using single-cell ligand-binding kinetics.
    May LT; Bridge LJ; Stoddart LA; Briddon SJ; Hill SJ
    FASEB J; 2011 Oct; 25(10):3465-76. PubMed ID: 21715680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moiety.
    Gao ZG; Jeong LS; Moon HR; Kim HO; Choi WJ; Shin DH; Elhalem E; Comin MJ; Melman N; Mamedova L; Gross AS; Rodriguez JB; Jacobson KA
    Biochem Pharmacol; 2004 Mar; 67(5):893-901. PubMed ID: 15104242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a new nucleoside template for human A3 adenosine receptor ligands: D-4'-thioadenosine derivatives without 4'-hydroxymethyl group as highly potent and selective antagonists.
    Jeong LS; Choe SA; Gunaga P; Kim HO; Lee HW; Lee SK; Tosh DK; Patel A; Palaniappan KK; Gao ZG; Jacobson KA; Moon HR
    J Med Chem; 2007 Jul; 50(14):3159-62. PubMed ID: 17555308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A₂A and A₃ adenosine receptor ligands.
    Hou X; Majik MS; Kim K; Pyee Y; Lee Y; Alexander V; Chung HJ; Lee HW; Chandra G; Lee JH; Park SG; Choi WJ; Kim HO; Phan K; Gao ZG; Jacobson KA; Choi S; Lee SK; Jeong LS
    J Med Chem; 2012 Jan; 55(1):342-56. PubMed ID: 22142423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and characterization of [76Br]-labeled high-affinity A3 adenosine receptor ligands for positron emission tomography.
    Kiesewetter DO; Lang L; Ma Y; Bhattacharjee AK; Gao ZG; Joshi BV; Melman A; de Castro S; Jacobson KA
    Nucl Med Biol; 2009 Jan; 36(1):3-10. PubMed ID: 19181263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.